News | January 10, 2025
Carbogen Amcis successfully completed Swissmedic inspection of its Vionnaz facility
The site’s GMP Certification has been successfully renewed
The site’s GMP Certification has been successfully renewed
The project is set to attract significant manufacturing investments of approximately Rs. 10,500 crore and is also projected to create around 1 lakh direct and indirect jobs
Menkes disease is a rare X-linked recessive pediatric disease caused by gene mutations of the copper transporter ATP7A
Parents, teachers, and caregivers play a vital role in spotting early signs of schizophrenia
Attruby is the first and only approved product with a label specifying near-complete stabilization of TTR
The new facility significantly increases Siegfried’s R&D capacity to drive development excellence and further growth
The MoU signed in 2022 has progressed and culminated in the subsumption of FOGSI-led Manyata initiative’s 20 quality standards across NABH’s Certification programs
Commercial license to Synaffix technologies follows a series of successful initial preclinical proof of concept studies
Union Government will provide a health cover of Rs. 5 lakh to any elderly person above 70 years of age
Extension of long-term collaboration includes construction of new customer-dedicated bioconjugation capacity in Visp (CH) and commercial antibody supply of a new ADC
Subscribe To Our Newsletter & Stay Updated
